InvestorsHub Logo
Followers 65
Posts 23975
Boards Moderated 0
Alias Born 11/23/2016

Re: catdaddy post# 453465

Tuesday, 03/05/2024 12:05:54 PM

Tuesday, March 05, 2024 12:05:54 PM

Post# of 463609
I chose to alert you to the chart on slide 18 and explain that abeta 42/40 isn't an adopted biomarker replacing/standing in for PET amyloid burden. One needs to know that fact when looking at the chart comparing abeta 42/40 from the Lecanemab and A2-73 trial results.

The longer we wait, the sooner we will get rich!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News